SEATTLE, Dec. 17, 2019 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de …
More Neoleukin Therapeutics Announces Pricing of $75.0 Million Public Offering Videos